ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,734.70
-0.89%
S&P ASX All Technology
3,069.70
-0.41%
Brent Oil
83.755
0.23%
US Dollar vs AUD
1.51979
-0.05%
Bitcoin
61,648.73
0.75%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Arix Bioscience Plc (ARIX)

  7. Arix Bioscience Plc (ARIX) News

ARIX

Arix Bioscience (ARIX)

Arix Bioscience Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:ARIX
DateTimeSourceHeadlineSymbolCompany
13/02/202419:00RNS Regulatory NewsLondon Stock Exchange Notice Cancellation - Arix Bioscience plcLSE:ARIXArix Bioscience Plc
12/02/202423:53Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience shares suspended ahead of RTW takeoverLSE:ARIXArix Bioscience Plc
12/02/202423:00EQS Regulatory NewsScheme EffectiveLSE:ARIXArix Bioscience Plc
12/02/202418:00EQS Regulatory NewsSuspension of Trading in SharesLSE:ARIXArix Bioscience Plc
07/02/202422:30EQS Regulatory NewsTransaction UpdateLSE:ARIXArix Bioscience Plc
29/01/202423:15EQS Regulatory NewsResults of First General MeetingLSE:ARIXArix Bioscience Plc
25/01/202404:30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
25/01/202404:30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
25/01/202404:30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
23/01/202418:00EQS Regulatory NewsUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
23/01/202418:00UK RegulatoryUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
23/01/202403:22Alliance NewsAlliance NewsIN BRIEF: RTW Biotech completes Arix investment in takeover run-upLSE:ARIXArix Bioscience Plc
22/01/202418:00EQS Regulatory NewsUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
22/01/202418:00UK RegulatoryUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
19/01/202422:29Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:ARIXArix Bioscience Plc
19/01/202418:01EQS Regulatory NewsFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
19/01/202418:01UK RegulatoryFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
19/01/202418:00EQS Regulatory NewsUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
19/01/202418:00UK RegulatoryUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
09/01/202404:15EQS Regulatory NewsPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
09/01/202404:15UK RegulatoryPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
05/01/202418:00EQS Regulatory NewsPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
05/01/202418:00UK RegulatoryPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
05/01/202404:30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
05/01/202404:30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
22/12/202322:00UK RegulatoryUpdate regarding timing of Proposed Scheme of ReconstructionLSE:ARIXArix Bioscience Plc
13/12/202318:00UK RegulatoryUnaudited NAV for November 2023LSE:ARIXArix Bioscience Plc
08/12/202318:00UK RegulatoryPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialLSE:ARIXArix Bioscience Plc
14/11/202303:00UK RegulatoryCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
10/11/202319:00UK RegulatoryPortfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
 Showing the most relevant articles for your search:LSE:ARIX

Your Recent History

NYSE
NKE
Nike
ASX
NCM
Newcrest Mining
ASX
NAB
National Australia Bank
FX
AUDUSD
AUD vs US Dollar
NYSE
XOM
Exxon Mobil
ASX
XFL
S&P ASX 50
NYSE
DIS
Walt Disney
ASX
BHP
BHP
ASX
WPL
Woodside Petroleum
FX
AUDJPY
AUD vs Yen
CCOM
SILVER
SILVER
ASX
WES
Wesfarmers
ASX
TLS
Telstra
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
GOOGL
Alphabet
ASX
FMG
Fortescue
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved